Shopping Cart 0
Cart Subtotal
AED 0

Oxford BioMedica Plc (OXB) - Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
AED 1376

Details

Oxford BioMedica Plc (OXB)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Oxford BioMedica plc (Oxford Biomedica) is a biopharmaceutical company involved in the development and commercialization of gene based medicines. It has LentiVector, a sector leading lentiviral vector delivery platform. Based on this platform the company has developed a portfolio of gene and cell therapy product candidates in ophthalmology, oncology and central nervous system (CNS) therapy areas. It has partnership and license agreement with other companies to develop potential gene and cell therapy products. The company has presence in different locations in Oxfordshire UK. Oxford BioMedica is headquartered in Oxford, the UK.

Oxford BioMedica Plc Key Recent Developments

Jun 28,2019: Oxford Biomedica: Repayment of debt facility

Jun 26,2019: OXB and Santen to develop gene therapy products for retinal disease

Jun 25,2019: Oxford Biomedica appoints Robert Ghenchev as Non-Executive Director

Mar 14,2019: Oxford Biomedica : preliminary results for the year ended 31 December 2018

Mar 12,2019: Microsoft unveils new platform to boost therapeutics production

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Oxford BioMedica Plc-Key Facts

Oxford BioMedica Plc-Key Employees

Oxford BioMedica Plc-Key Employee Biographies

Oxford BioMedica Plc-Major Products and Services

Oxford BioMedica Plc-History

Oxford BioMedica Plc-Company Statement

Oxford BioMedica Plc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Oxford BioMedica Plc-Business Description

Oxford BioMedica Plc-SWOT Analysis

SWOT Analysis-Overview

Oxford BioMedica Plc-Strengths

Oxford BioMedica Plc-Weaknesses

Oxford BioMedica Plc-Opportunities

Oxford BioMedica Plc-Threats

Oxford BioMedica Plc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Oxford BioMedica Plc, Recent Deals Summary

Section 5-Company's Recent Developments

Jun 28, 2019: Oxford Biomedica: Repayment of debt facility

Jun 26, 2019: OXB and Santen to develop gene therapy products for retinal disease

Jun 25, 2019: Oxford Biomedica appoints Robert Ghenchev as Non-Executive Director

Mar 14, 2019: Oxford Biomedica : preliminary results for the year ended 31 December 2018

Mar 12, 2019: Microsoft unveils new platform to boost therapeutics production

Mar 12, 2019: Oxford Biomedica announces R&D collaboration with Microsoft to improve gene and cell therapy manufacturing using the intelligent cloud and machine learning

Mar 05, 2019: CGT Catapult Celebrates First Successful Months of Novel Apprenticeship Programme to Secure Future Skills for Advanced Therapies

Feb 21, 2019: International biomed specialist appoints WHP to deliver key expansion project

Nov 23, 2018: Oxford BioMedica announces new digital framework initiative to streamline the production of next-generation medicines with cash injection from Innovate UK

Nov 22, 2018: Manufacturing of life-enhancing medicines boosted by new government funding

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Oxford BioMedica Plc, Performance Chart (2014-2018)

Oxford BioMedica Plc, Ratio Charts

Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Oxford BioMedica Plc, Key Facts

Oxford BioMedica Plc, Key Employees

Oxford BioMedica Plc, Key Employee Biographies

Oxford BioMedica Plc, Major Products and Services

Oxford BioMedica Plc, History

Oxford BioMedica Plc, Other Locations

Oxford BioMedica Plc, Subsidiaries

Oxford BioMedica Plc, Key Competitors

Oxford BioMedica Plc, Ratios based on current share price

Oxford BioMedica Plc, Annual Ratios

Oxford BioMedica Plc, Annual Ratios (Cont...1)

Oxford BioMedica Plc, Interim Ratios

Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Oxford BioMedica Plc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Oxford BioMedica Plc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Vernalis Plc

Transgene SA

Summit Therapeutics Plc

Proteome Sciences Plc

Phynova Group Ltd

Almac Group Ltd

Alliance Pharma Plc

Agenus Inc

Company Profile

Company Profile Title

Oxford BioMedica Plc (OXB)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Oxford BioMedica plc (Oxford Biomedica) is a biopharmaceutical company involved in the development and commercialization of gene based medicines. It has LentiVector, a sector leading lentiviral vector delivery platform. Based on this platform the company has developed a portfolio of gene and cell therapy product candidates in ophthalmology, oncology and central nervous system (CNS) therapy areas. It has partnership and license agreement with other companies to develop potential gene and cell therapy products. The company has presence in different locations in Oxfordshire UK. Oxford BioMedica is headquartered in Oxford, the UK.

Oxford BioMedica Plc Key Recent Developments

Jun 28,2019: Oxford Biomedica: Repayment of debt facility

Jun 26,2019: OXB and Santen to develop gene therapy products for retinal disease

Jun 25,2019: Oxford Biomedica appoints Robert Ghenchev as Non-Executive Director

Mar 14,2019: Oxford Biomedica : preliminary results for the year ended 31 December 2018

Mar 12,2019: Microsoft unveils new platform to boost therapeutics production

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1-About the Company

Oxford BioMedica Plc-Key Facts

Oxford BioMedica Plc-Key Employees

Oxford BioMedica Plc-Key Employee Biographies

Oxford BioMedica Plc-Major Products and Services

Oxford BioMedica Plc-History

Oxford BioMedica Plc-Company Statement

Oxford BioMedica Plc-Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2-Company Analysis

Company Overview

Oxford BioMedica Plc-Business Description

Oxford BioMedica Plc-SWOT Analysis

SWOT Analysis-Overview

Oxford BioMedica Plc-Strengths

Oxford BioMedica Plc-Weaknesses

Oxford BioMedica Plc-Opportunities

Oxford BioMedica Plc-Threats

Oxford BioMedica Plc-Key Competitors

Section 3-Company Financial Ratios

Financial Ratios-Capital Market Ratios

Financial Ratios-Annual Ratios

Performance Chart

Financial Performance

Financial Ratios-Interim Ratios

Financial Ratios-Ratio Charts

Section 4-Company's Lifesciences Financial Deals and Alliances

Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Oxford BioMedica Plc, Recent Deals Summary

Section 5-Company's Recent Developments

Jun 28, 2019: Oxford Biomedica: Repayment of debt facility

Jun 26, 2019: OXB and Santen to develop gene therapy products for retinal disease

Jun 25, 2019: Oxford Biomedica appoints Robert Ghenchev as Non-Executive Director

Mar 14, 2019: Oxford Biomedica : preliminary results for the year ended 31 December 2018

Mar 12, 2019: Microsoft unveils new platform to boost therapeutics production

Mar 12, 2019: Oxford Biomedica announces R&D collaboration with Microsoft to improve gene and cell therapy manufacturing using the intelligent cloud and machine learning

Mar 05, 2019: CGT Catapult Celebrates First Successful Months of Novel Apprenticeship Programme to Secure Future Skills for Advanced Therapies

Feb 21, 2019: International biomed specialist appoints WHP to deliver key expansion project

Nov 23, 2018: Oxford BioMedica announces new digital framework initiative to streamline the production of next-generation medicines with cash injection from Innovate UK

Nov 22, 2018: Manufacturing of life-enhancing medicines boosted by new government funding

Section 6-Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer


List Of Figure

List of Figures

Oxford BioMedica Plc, Performance Chart (2014-2018)

Oxford BioMedica Plc, Ratio Charts

Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019


List Of Table

List of Tables

Oxford BioMedica Plc, Key Facts

Oxford BioMedica Plc, Key Employees

Oxford BioMedica Plc, Key Employee Biographies

Oxford BioMedica Plc, Major Products and Services

Oxford BioMedica Plc, History

Oxford BioMedica Plc, Other Locations

Oxford BioMedica Plc, Subsidiaries

Oxford BioMedica Plc, Key Competitors

Oxford BioMedica Plc, Ratios based on current share price

Oxford BioMedica Plc, Annual Ratios

Oxford BioMedica Plc, Annual Ratios (Cont...1)

Oxford BioMedica Plc, Interim Ratios

Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Oxford BioMedica Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Oxford BioMedica Plc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Oxford BioMedica Plc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Vernalis Plc

Transgene SA

Summit Therapeutics Plc

Proteome Sciences Plc

Phynova Group Ltd

Almac Group Ltd

Alliance Pharma Plc

Agenus Inc